Current through Register Vol. 49, No. 8, August 19, 2024
Section 151.361 - MANUFACTURER DISCLOSURESubdivision 1.After January 1, 1976.The manufacturer, packager, or distributor of any human use legend drug sold, delivered, or offered for sale in the state of Minnesota after January 1, 1976 must have printed on the label on the immediate container of the drug the name and address of the manufacturer of the finished dosage form of the drug.
Subd. 2.After January 1, 1983.(a) No legend drug in solid oral dosage form may be manufactured, packaged or distributed for sale in this state after January 1, 1983 unless it is clearly marked or imprinted with a symbol, number, company name, words, letters, national drug code or other mark uniquely identifiable to that drug product. An identifying mark or imprint made as required by federal law or by the federal Food and Drug Administration shall be deemed to be in compliance with this section.(b) The Board of Pharmacy may grant exemptions from the requirements of this section on its own initiative or upon application of a manufacturer, packager, or distributor indicating size or other characteristics that render the product impractical for the imprinting required by this section.Subd. 3.Penalty.Failure to comply with the requirements of this section shall subject a drug to embargo in accordance with section 151.38.
1975 c 101 s 4; 1981 c 206 s 1; 2014 c 291 art 5 s 12
Amended by 2014 Minn. Laws, ch. 291,s 5-12, eff. 8/1/2014.